China’s Abogen raises $700M series C for mRNA trials, catapulting itself into the big leagues
China’s Abogen raises $700M series C for mRNA trials, catapulting [...]
China’s Abogen raises $700M series C for mRNA trials, catapulting [...]
Despite upbeat tones from analysts, Fate Therapeutics’ stock drops on [...]
After Bristol Myers buyout, MyoKardia’s clinical ops lead jumps ship [...]
Visus, with one drug chasing AbbVie, inks deals to grow [...]
Biotech co-founder settles accusations of faked research data ntaylor Thu, [...]
CRISPR pioneer Feng Zhang’s latest work delivers mRNA, gene therapy [...]
Lilly, with Alzheimer’s in its crosshairs, forms new neuroscience unit, [...]
Going big: Bain reels in $1.9B for more mammoth biotech [...]
The 7-year itch? Boehringer culls $600M cancer pact with CureVac, [...]
Novartis-backed Penn study proposes boosting CAR-T responses in CLL by [...]